CN Stock MarketDetailed Quotes

002100 Tecon Biology Co.Ltd

Watchlist
  • 6.49
  • -0.01-0.15%
Market Closed Oct 16 15:00 CST
8.86BMarket Cap-13867P/E (TTM)

Tecon Biology Co.Ltd Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

All
YOY yoy
Hide blank lines yoy
(Q6)Jun 30, 2024
(Q3)Mar 31, 2024
(FY)Dec 31, 2023
(Q9)Sep 30, 2023
(Q6)Jun 30, 2023
(Q3)Mar 31, 2023
(FY)Dec 31, 2022
(Q9)Sep 30, 2022
(Q6)Jun 30, 2022
(Q3)Mar 31, 2022
Assets
Current assets
Money funds
-25.54%2.86B
-31.02%2.68B
-15.00%2.82B
-35.08%3.84B
57.11%3.84B
67.53%3.89B
-3.05%3.32B
96.68%5.92B
37.29%2.45B
24.66%2.32B
Transactional financial assets
-99.48%522.51K
--472.63K
-99.93%473.08K
----
--100M
----
--650.94M
----
----
----
Notes receivable and accounts receivable
-16.17%613.5M
-3.53%712.26M
7.93%430.75M
7.39%817.99M
33.91%731.84M
27.87%738.31M
26.94%399.1M
35.20%761.72M
17.61%546.5M
14.18%577.39M
-Notes receivable
-32.03%13.47M
67.52%26.64M
-11.60%9.62M
654.60%16.46M
306.30%19.82M
6.78%15.9M
30.07%10.88M
-79.03%2.18M
11.89%4.88M
-5.26%14.89M
-Accounts receivable
-15.73%600.02M
-5.09%685.63M
8.48%421.13M
5.53%801.54M
31.46%712.02M
28.43%722.41M
26.86%388.22M
37.35%759.54M
17.67%541.62M
14.80%562.5M
Other receivables (including interest and dividends)
-5.95%283.77M
-16.98%256M
-13.60%259.14M
3.05%351.37M
-2.96%301.73M
-17.93%308.36M
-8.72%299.94M
-14.27%340.97M
-18.31%310.92M
-1.42%375.73M
-Other receivable
-5.95%283.77M
----
-13.60%259.14M
----
-2.96%301.73M
----
-8.72%299.94M
----
-18.31%310.92M
----
Advance payment
-20.41%316.22M
-27.30%484.52M
-65.96%386.57M
-52.75%372.48M
-23.27%397.31M
-24.24%666.45M
42.71%1.14B
13.60%788.37M
-23.40%517.77M
-31.37%879.64M
Inventories
-15.59%4.32B
-30.13%4.74B
-24.63%4.55B
-17.73%3.24B
-0.22%5.12B
16.73%6.78B
15.07%6.04B
30.87%3.93B
7.45%5.13B
-3.25%5.81B
Receivable financing
--2.29M
----
397.94%13.53M
----
----
----
1,371.03%2.72M
----
----
----
Other current assets
2.55%483.24M
-19.20%479.93M
-11.04%475.88M
-17.10%333.62M
-4.24%471.21M
14.09%593.93M
7.35%534.95M
44.55%402.43M
35.72%492.07M
2.92%520.59M
Total current assets
-18.97%8.9B
-27.97%9.36B
-27.71%8.96B
-26.23%8.96B
16.21%10.98B
23.87%12.99B
16.81%12.4B
52.71%12.15B
11.36%9.45B
-0.64%10.49B
Non Current assets
Long-term equity investment
-12.16%33.83M
74.83%37.34M
-65.76%36.11M
-70.76%38.84M
-69.39%38.51M
-82.80%21.36M
-2.43%105.45M
10.88%132.83M
10.53%125.8M
14.09%124.16M
Fixed assets
3.84%5.28B
----
4.05%5.33B
----
3.70%5.08B
----
18.10%5.13B
----
28.09%4.9B
----
Constru in process
0.69%842.66M
----
91.63%814.7M
----
86.76%836.88M
----
-52.47%425.14M
----
-42.20%448.09M
----
Productive biological assets
-19.38%292.7M
-22.07%295.55M
-10.65%320.76M
-5.62%363.42M
-17.58%363.08M
-7.13%379.26M
0.79%359M
14.20%385.07M
21.82%440.5M
31.21%408.4M
Intangible assets
13.12%385.71M
40.79%384.78M
34.44%360.84M
22.89%337.17M
22.06%340.96M
-2.63%273.3M
-1.36%268.4M
11.87%274.36M
11.73%279.34M
17.17%280.68M
Development expenditure
-89.57%750K
-52.15%6.21M
-9.52%7.01M
-82.06%9.06M
-85.09%7.19M
-55.59%12.98M
--7.75M
72.71%50.49M
64.99%48.24M
0.00%29.24M
Goodwill
-17.02%178.48M
-47.96%178.48M
702.42%178.48M
867.07%215.1M
867.07%215.1M
1,441.92%342.96M
0.00%22.24M
-3.54%22.24M
-3.54%22.24M
--22.24M
Long deferred expense
-3.74%20.84M
12.31%23.45M
4.18%24.04M
-3.02%21.88M
-15.07%21.65M
-7.11%20.87M
-11.83%23.08M
-63.49%22.57M
-33.56%25.5M
-71.83%22.47M
Deferred tax assets
172.55%74.66M
72.12%74.12M
82.53%72.18M
154.77%45.81M
49.64%27.39M
115.31%43.06M
146.29%39.54M
64.94%17.98M
62.78%18.31M
96.32%20M
Usufruct assets
13.07%631.36M
16.12%652.15M
14.91%623.65M
15.81%577.34M
18.20%558.38M
15.15%561.64M
10.90%542.71M
21.81%498.52M
25.61%472.42M
66.92%487.73M
Other non current assets
-57.13%17.97M
-99.20%269.78K
-58.77%19.34M
--41.93M
--41.92M
--33.69M
3,561.01%46.9M
----
----
----
Total non current assets
2.96%7.75B
5.76%7.81B
11.84%7.79B
12.32%7.65B
11.09%7.53B
11.83%7.38B
6.74%6.97B
10.45%6.82B
16.82%6.78B
22.55%6.6B
Total assets
-10.05%16.65B
-15.75%17.17B
-13.48%16.75B
-12.38%16.62B
14.07%18.51B
19.22%20.37B
12.97%19.36B
34.25%18.96B
13.58%16.23B
7.20%17.09B
Liabilities
Current liabilities
Short term loan
1.60%2.7B
-16.66%3.18B
3.26%3.32B
-64.90%1.1B
-17.96%2.65B
0.28%3.82B
-19.75%3.21B
18.53%3.15B
51.15%3.23B
4.35%3.81B
Notes payable and accounts payable
6.27%580.5M
25.42%653.57M
14.07%697.12M
23.17%638.84M
26.31%546.26M
-7.61%521.13M
31.36%611.11M
7.44%518.67M
-13.99%432.48M
38.68%564.08M
-Notes payable
463.86%23.79M
--21.08M
--5.3M
--8.41M
--4.22M
----
----
----
----
----
-Accounts payable
2.71%556.71M
21.37%632.49M
13.21%691.82M
21.55%630.42M
25.33%542.04M
-7.61%521.13M
31.36%611.11M
10.18%518.67M
-11.89%432.48M
57.10%564.08M
Contract liabilities
-32.28%498.67M
-1.51%481.41M
-6.82%440.23M
-33.47%346.61M
28.67%736.36M
-35.85%488.79M
-30.64%472.48M
24.38%520.94M
-35.03%572.29M
-17.49%761.99M
Advance receipts
----
----
-41.79%48.51K
----
----
----
-82.39%83.33K
----
----
----
Salaries payable
-11.65%220.16M
-14.11%267.63M
-5.01%297.56M
-12.82%243.63M
-11.12%249.18M
5.14%311.59M
-11.95%313.24M
-5.78%279.45M
-3.05%280.34M
-32.39%296.36M
Taxs payable
-54.90%9.1M
66.33%40.72M
29.09%31.78M
172.86%28.72M
29.46%20.18M
-10.61%24.48M
32.71%24.62M
-57.41%10.53M
-66.18%15.59M
13.00%27.38M
Other payable (including interest and dividends)
-8.81%693.75M
-29.92%693.29M
-0.38%731.35M
5.82%769.22M
14.02%760.8M
77.35%989.22M
21.62%734.11M
34.57%726.93M
13.54%667.23M
5.15%557.78M
-Dividend payable
----
----
----
----
0.00%48.3M
----
-85.94%2.92M
----
-17.42%48.3M
----
-Other payable
-2.63%693.75M
----
0.02%731.35M
----
15.12%712.5M
----
25.45%731.19M
----
16.97%618.93M
----
Non current liabilities due within one year
4.99%1.6B
57.44%1.71B
104.82%1.49B
277.40%2.27B
102.89%1.53B
93.94%1.08B
-2.00%726.68M
-20.48%602.73M
19.10%752.09M
-27.16%558.66M
Other current liabilities
-19.90%64.23M
-15.17%66.01M
-23.21%81.31M
-8.18%60.64M
20.84%80.2M
0.57%77.81M
17.06%105.9M
20.47%66.04M
-4.71%66.37M
-21.73%77.38M
Total current liabilities
-3.16%6.36B
-3.00%7.1B
14.16%7.09B
-7.12%5.47B
8.98%6.57B
8.84%7.32B
-10.95%6.21B
12.52%5.89B
17.15%6.03B
-1.71%6.72B
Current liabilities
Long term loan
-41.99%1.48B
-45.79%1.56B
-60.89%1.23B
-38.60%1.77B
24.82%2.55B
27.68%2.88B
59.52%3.13B
44.20%2.89B
5.58%2.05B
55.99%2.25B
Bonds payable
----
----
----
----
----
----
----
-4.72%90.71M
-4.55%91.23M
-10.12%92.67M
Deferred tax liabilities
2,310.20%17.22M
2,374.31%17.68M
1,150.15%18.13M
4,135.14%16.55M
82.80%714.38K
82.80%714.38K
94.13%1.45M
-13.05%390.8K
-13.05%390.8K
-13.05%390.8K
Long term deferred income
48.88%144.51M
60.50%144.54M
63.74%143.29M
30.71%109.17M
26.18%97.07M
17.40%90.06M
8.01%87.51M
1.46%83.52M
-10.05%76.93M
-12.45%76.71M
Lease liabilities
32.60%494.54M
27.32%409.42M
19.96%362.93M
26.62%453.64M
6.28%372.97M
-5.91%321.55M
2.70%302.53M
9.88%358.27M
35.03%350.93M
34.40%341.74M
Total non current liabilities
-29.32%2.14B
-35.21%2.13B
-50.36%1.75B
-31.23%2.35B
17.89%3.02B
18.98%3.29B
44.75%3.52B
36.46%3.42B
7.82%2.56B
46.29%2.77B
Total liabilities
-11.40%8.5B
-13.00%9.23B
-9.20%8.84B
-15.98%7.82B
11.64%9.6B
11.79%10.61B
3.47%9.73B
20.28%9.31B
14.20%8.6B
8.69%9.49B
Shareholders equity
Paid-in capital
0.77%1.37B
0.79%1.37B
0.81%1.37B
0.05%1.36B
0.04%1.35B
0.04%1.35B
0.04%1.35B
25.83%1.35B
25.83%1.35B
25.92%1.35B
Other equity instruments
----
----
----
-6.48%3.37M
-4.89%3.45M
-4.55%3.52M
-4.47%3.6M
-5.10%3.6M
-4.91%3.63M
-10.48%3.69M
Capital reserve funds
0.75%3.94B
0.15%3.94B
2.60%3.94B
3.02%3.91B
18.49%3.91B
19.24%3.94B
16.34%3.84B
149.17%3.8B
118.01%3.3B
121.65%3.3B
Surplus reserve funds
6.31%466.77M
6.31%466.77M
6.31%466.77M
58.80%439.08M
58.80%439.08M
58.80%439.08M
59.69%439.08M
21.66%276.49M
21.66%276.49M
21.66%276.49M
Retained profit
-44.74%823.8M
-72.26%635.46M
-74.39%581.39M
-42.16%1.43B
-29.79%1.49B
6.50%2.29B
4.72%2.27B
-10.32%2.48B
-33.61%2.12B
-42.68%2.15B
Other composite income
-54.34%10.28M
-115.39%-1.74M
3,494.81%51.12M
120.59%4.52M
160.57%22.52M
112.70%11.27M
115.50%1.42M
-163.54%-21.94M
-332.78%-37.18M
---88.75M
Ordinary risk reserve funds
0.00%3.85M
0.00%3.85M
0.00%3.85M
11.53%3.85M
11.53%3.85M
11.53%3.85M
11.53%3.85M
35.11%3.46M
35.11%3.46M
35.11%3.46M
Shareholders equity without minority interests
-8.51%6.61B
-20.25%6.41B
-19.01%6.41B
-9.38%7.15B
2.86%7.23B
14.83%8.04B
11.52%7.92B
40.14%7.89B
16.35%7.03B
6.87%7B
Minority interests
-8.89%1.54B
-11.69%1.53B
-12.28%1.5B
-6.76%1.64B
178.21%1.69B
187.09%1.73B
170.08%1.71B
133.61%1.76B
-16.11%607.09M
-9.14%602.61M
Total shareholder equity
-8.58%8.15B
-18.73%7.94B
-17.81%7.91B
-8.90%8.8B
16.81%8.92B
28.48%9.77B
24.53%9.63B
51.18%9.66B
12.88%7.63B
5.40%7.6B
Total liabilityies and equity
-10.05%16.65B
-15.75%17.17B
-13.48%16.75B
-12.38%16.62B
14.07%18.51B
19.22%20.37B
12.97%19.36B
34.25%18.96B
13.58%16.23B
7.20%17.09B
Currency Unit
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
CNY
Accounting Standards
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
CAS (2007)
Audit Opinions
--
--
Unqualified opinion
--
--
--
Unqualified opinion
--
--
--
Auditor
--
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
--
Sigma Certified Public Accountants (Special General Partnership)
--
--
--
(Q6)Jun 30, 2024(Q3)Mar 31, 2024(FY)Dec 31, 2023(Q9)Sep 30, 2023(Q6)Jun 30, 2023(Q3)Mar 31, 2023(FY)Dec 31, 2022(Q9)Sep 30, 2022(Q6)Jun 30, 2022(Q3)Mar 31, 2022
Assets
Current assets
Money funds -25.54%2.86B-31.02%2.68B-15.00%2.82B-35.08%3.84B57.11%3.84B67.53%3.89B-3.05%3.32B96.68%5.92B37.29%2.45B24.66%2.32B
Transactional financial assets -99.48%522.51K--472.63K-99.93%473.08K------100M------650.94M------------
Notes receivable and accounts receivable -16.17%613.5M-3.53%712.26M7.93%430.75M7.39%817.99M33.91%731.84M27.87%738.31M26.94%399.1M35.20%761.72M17.61%546.5M14.18%577.39M
-Notes receivable -32.03%13.47M67.52%26.64M-11.60%9.62M654.60%16.46M306.30%19.82M6.78%15.9M30.07%10.88M-79.03%2.18M11.89%4.88M-5.26%14.89M
-Accounts receivable -15.73%600.02M-5.09%685.63M8.48%421.13M5.53%801.54M31.46%712.02M28.43%722.41M26.86%388.22M37.35%759.54M17.67%541.62M14.80%562.5M
Other receivables (including interest and dividends) -5.95%283.77M-16.98%256M-13.60%259.14M3.05%351.37M-2.96%301.73M-17.93%308.36M-8.72%299.94M-14.27%340.97M-18.31%310.92M-1.42%375.73M
-Other receivable -5.95%283.77M-----13.60%259.14M-----2.96%301.73M-----8.72%299.94M-----18.31%310.92M----
Advance payment -20.41%316.22M-27.30%484.52M-65.96%386.57M-52.75%372.48M-23.27%397.31M-24.24%666.45M42.71%1.14B13.60%788.37M-23.40%517.77M-31.37%879.64M
Inventories -15.59%4.32B-30.13%4.74B-24.63%4.55B-17.73%3.24B-0.22%5.12B16.73%6.78B15.07%6.04B30.87%3.93B7.45%5.13B-3.25%5.81B
Receivable financing --2.29M----397.94%13.53M------------1,371.03%2.72M------------
Other current assets 2.55%483.24M-19.20%479.93M-11.04%475.88M-17.10%333.62M-4.24%471.21M14.09%593.93M7.35%534.95M44.55%402.43M35.72%492.07M2.92%520.59M
Total current assets -18.97%8.9B-27.97%9.36B-27.71%8.96B-26.23%8.96B16.21%10.98B23.87%12.99B16.81%12.4B52.71%12.15B11.36%9.45B-0.64%10.49B
Non Current assets
Long-term equity investment -12.16%33.83M74.83%37.34M-65.76%36.11M-70.76%38.84M-69.39%38.51M-82.80%21.36M-2.43%105.45M10.88%132.83M10.53%125.8M14.09%124.16M
Fixed assets 3.84%5.28B----4.05%5.33B----3.70%5.08B----18.10%5.13B----28.09%4.9B----
Constru in process 0.69%842.66M----91.63%814.7M----86.76%836.88M-----52.47%425.14M-----42.20%448.09M----
Productive biological assets -19.38%292.7M-22.07%295.55M-10.65%320.76M-5.62%363.42M-17.58%363.08M-7.13%379.26M0.79%359M14.20%385.07M21.82%440.5M31.21%408.4M
Intangible assets 13.12%385.71M40.79%384.78M34.44%360.84M22.89%337.17M22.06%340.96M-2.63%273.3M-1.36%268.4M11.87%274.36M11.73%279.34M17.17%280.68M
Development expenditure -89.57%750K-52.15%6.21M-9.52%7.01M-82.06%9.06M-85.09%7.19M-55.59%12.98M--7.75M72.71%50.49M64.99%48.24M0.00%29.24M
Goodwill -17.02%178.48M-47.96%178.48M702.42%178.48M867.07%215.1M867.07%215.1M1,441.92%342.96M0.00%22.24M-3.54%22.24M-3.54%22.24M--22.24M
Long deferred expense -3.74%20.84M12.31%23.45M4.18%24.04M-3.02%21.88M-15.07%21.65M-7.11%20.87M-11.83%23.08M-63.49%22.57M-33.56%25.5M-71.83%22.47M
Deferred tax assets 172.55%74.66M72.12%74.12M82.53%72.18M154.77%45.81M49.64%27.39M115.31%43.06M146.29%39.54M64.94%17.98M62.78%18.31M96.32%20M
Usufruct assets 13.07%631.36M16.12%652.15M14.91%623.65M15.81%577.34M18.20%558.38M15.15%561.64M10.90%542.71M21.81%498.52M25.61%472.42M66.92%487.73M
Other non current assets -57.13%17.97M-99.20%269.78K-58.77%19.34M--41.93M--41.92M--33.69M3,561.01%46.9M------------
Total non current assets 2.96%7.75B5.76%7.81B11.84%7.79B12.32%7.65B11.09%7.53B11.83%7.38B6.74%6.97B10.45%6.82B16.82%6.78B22.55%6.6B
Total assets -10.05%16.65B-15.75%17.17B-13.48%16.75B-12.38%16.62B14.07%18.51B19.22%20.37B12.97%19.36B34.25%18.96B13.58%16.23B7.20%17.09B
Liabilities
Current liabilities
Short term loan 1.60%2.7B-16.66%3.18B3.26%3.32B-64.90%1.1B-17.96%2.65B0.28%3.82B-19.75%3.21B18.53%3.15B51.15%3.23B4.35%3.81B
Notes payable and accounts payable 6.27%580.5M25.42%653.57M14.07%697.12M23.17%638.84M26.31%546.26M-7.61%521.13M31.36%611.11M7.44%518.67M-13.99%432.48M38.68%564.08M
-Notes payable 463.86%23.79M--21.08M--5.3M--8.41M--4.22M--------------------
-Accounts payable 2.71%556.71M21.37%632.49M13.21%691.82M21.55%630.42M25.33%542.04M-7.61%521.13M31.36%611.11M10.18%518.67M-11.89%432.48M57.10%564.08M
Contract liabilities -32.28%498.67M-1.51%481.41M-6.82%440.23M-33.47%346.61M28.67%736.36M-35.85%488.79M-30.64%472.48M24.38%520.94M-35.03%572.29M-17.49%761.99M
Advance receipts ---------41.79%48.51K-------------82.39%83.33K------------
Salaries payable -11.65%220.16M-14.11%267.63M-5.01%297.56M-12.82%243.63M-11.12%249.18M5.14%311.59M-11.95%313.24M-5.78%279.45M-3.05%280.34M-32.39%296.36M
Taxs payable -54.90%9.1M66.33%40.72M29.09%31.78M172.86%28.72M29.46%20.18M-10.61%24.48M32.71%24.62M-57.41%10.53M-66.18%15.59M13.00%27.38M
Other payable (including interest and dividends) -8.81%693.75M-29.92%693.29M-0.38%731.35M5.82%769.22M14.02%760.8M77.35%989.22M21.62%734.11M34.57%726.93M13.54%667.23M5.15%557.78M
-Dividend payable ----------------0.00%48.3M-----85.94%2.92M-----17.42%48.3M----
-Other payable -2.63%693.75M----0.02%731.35M----15.12%712.5M----25.45%731.19M----16.97%618.93M----
Non current liabilities due within one year 4.99%1.6B57.44%1.71B104.82%1.49B277.40%2.27B102.89%1.53B93.94%1.08B-2.00%726.68M-20.48%602.73M19.10%752.09M-27.16%558.66M
Other current liabilities -19.90%64.23M-15.17%66.01M-23.21%81.31M-8.18%60.64M20.84%80.2M0.57%77.81M17.06%105.9M20.47%66.04M-4.71%66.37M-21.73%77.38M
Total current liabilities -3.16%6.36B-3.00%7.1B14.16%7.09B-7.12%5.47B8.98%6.57B8.84%7.32B-10.95%6.21B12.52%5.89B17.15%6.03B-1.71%6.72B
Current liabilities
Long term loan -41.99%1.48B-45.79%1.56B-60.89%1.23B-38.60%1.77B24.82%2.55B27.68%2.88B59.52%3.13B44.20%2.89B5.58%2.05B55.99%2.25B
Bonds payable -----------------------------4.72%90.71M-4.55%91.23M-10.12%92.67M
Deferred tax liabilities 2,310.20%17.22M2,374.31%17.68M1,150.15%18.13M4,135.14%16.55M82.80%714.38K82.80%714.38K94.13%1.45M-13.05%390.8K-13.05%390.8K-13.05%390.8K
Long term deferred income 48.88%144.51M60.50%144.54M63.74%143.29M30.71%109.17M26.18%97.07M17.40%90.06M8.01%87.51M1.46%83.52M-10.05%76.93M-12.45%76.71M
Lease liabilities 32.60%494.54M27.32%409.42M19.96%362.93M26.62%453.64M6.28%372.97M-5.91%321.55M2.70%302.53M9.88%358.27M35.03%350.93M34.40%341.74M
Total non current liabilities -29.32%2.14B-35.21%2.13B-50.36%1.75B-31.23%2.35B17.89%3.02B18.98%3.29B44.75%3.52B36.46%3.42B7.82%2.56B46.29%2.77B
Total liabilities -11.40%8.5B-13.00%9.23B-9.20%8.84B-15.98%7.82B11.64%9.6B11.79%10.61B3.47%9.73B20.28%9.31B14.20%8.6B8.69%9.49B
Shareholders equity
Paid-in capital 0.77%1.37B0.79%1.37B0.81%1.37B0.05%1.36B0.04%1.35B0.04%1.35B0.04%1.35B25.83%1.35B25.83%1.35B25.92%1.35B
Other equity instruments -------------6.48%3.37M-4.89%3.45M-4.55%3.52M-4.47%3.6M-5.10%3.6M-4.91%3.63M-10.48%3.69M
Capital reserve funds 0.75%3.94B0.15%3.94B2.60%3.94B3.02%3.91B18.49%3.91B19.24%3.94B16.34%3.84B149.17%3.8B118.01%3.3B121.65%3.3B
Surplus reserve funds 6.31%466.77M6.31%466.77M6.31%466.77M58.80%439.08M58.80%439.08M58.80%439.08M59.69%439.08M21.66%276.49M21.66%276.49M21.66%276.49M
Retained profit -44.74%823.8M-72.26%635.46M-74.39%581.39M-42.16%1.43B-29.79%1.49B6.50%2.29B4.72%2.27B-10.32%2.48B-33.61%2.12B-42.68%2.15B
Other composite income -54.34%10.28M-115.39%-1.74M3,494.81%51.12M120.59%4.52M160.57%22.52M112.70%11.27M115.50%1.42M-163.54%-21.94M-332.78%-37.18M---88.75M
Ordinary risk reserve funds 0.00%3.85M0.00%3.85M0.00%3.85M11.53%3.85M11.53%3.85M11.53%3.85M11.53%3.85M35.11%3.46M35.11%3.46M35.11%3.46M
Shareholders equity without minority interests -8.51%6.61B-20.25%6.41B-19.01%6.41B-9.38%7.15B2.86%7.23B14.83%8.04B11.52%7.92B40.14%7.89B16.35%7.03B6.87%7B
Minority interests -8.89%1.54B-11.69%1.53B-12.28%1.5B-6.76%1.64B178.21%1.69B187.09%1.73B170.08%1.71B133.61%1.76B-16.11%607.09M-9.14%602.61M
Total shareholder equity -8.58%8.15B-18.73%7.94B-17.81%7.91B-8.90%8.8B16.81%8.92B28.48%9.77B24.53%9.63B51.18%9.66B12.88%7.63B5.40%7.6B
Total liabilityies and equity -10.05%16.65B-15.75%17.17B-13.48%16.75B-12.38%16.62B14.07%18.51B19.22%20.37B12.97%19.36B34.25%18.96B13.58%16.23B7.20%17.09B
Currency Unit CNYCNYCNYCNYCNYCNYCNYCNYCNYCNY
Accounting Standards CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)CAS (2007)
Audit Opinions ----Unqualified opinion------Unqualified opinion------
Auditor ----Sigma Certified Public Accountants (Special General Partnership)------Sigma Certified Public Accountants (Special General Partnership)------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
CN
Overall
Symbol
Latest Price
% Chg

No Data